Dow Jones

39,118.86

-0.12%

Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Get Started

Home
Investing
Stocks
USA
USOTC
IR BioSciences Holdings Inc New (CE) (IRBS)
IR BioSciences Holdings Inc New (CE) (IRBS) News

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:IRBS

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
24/05/2011	22:28	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
16/05/2011	20:11	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/03/2011	17:54	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/03/2011	22:29	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/11/2010	21:12	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
12/11/2010	13:27	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
28/10/2010	14:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/10/2010	21:37	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
08/09/2010	12:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/08/2010	19:21	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
25/08/2010	14:00	GlobeNewswire Inc.	University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
23/08/2010	22:15	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
13/08/2010	21:12	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/08/2010	13:27	Marketwired	/ CORRECTION - ImmuneRegen BioSciences	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/08/2010	12:00	Marketwired	ImmuneRegen BioSciences Completes Successful Reduction of Debt	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/07/2010	11:01	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/05/2010	20:40	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
17/05/2010	16:51	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
30/04/2010	22:17	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/04/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Me	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
21/04/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indica	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
19/04/2010	18:00	Marketwired	ImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
15/04/2010	21:20	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
01/04/2010	21:01	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/03/2010	13:00	Marketwired	ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fi	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/02/2010	13:00	Marketwired	Fred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/01/2010	13:00	Marketwired	National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/01/2010	19:54	Marketwired	IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/01/2010	13:00	Marketwired	ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/12/2009	13:00	Marketwired	ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)